Sinopharm Tech Holdings Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 0/6
Sinopharm Tech Holdings has a total shareholder equity of HK$-182.5M and total debt of HK$10.0M, which brings its debt-to-equity ratio to -5.5%. Its total assets and total liabilities are HK$46.2M and HK$228.7M respectively.
Anahtar bilgiler
-5.5%
Borç/özkaynak oranı
HK$10.00m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | HK$8.51m |
| Eşitlik | -HK$182.51m |
| Toplam yükümlülükler | HK$228.74m |
| Toplam varlıklar | HK$46.23m |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Is Sinopharm Tech Holdings Limited's (HKG:8156) Shareholder Ownership Skewed Towards Insiders?
Feb 02
How Much Did Sinopharm Tech Holdings'(HKG:8156) Shareholders Earn From Share Price Movements Over The Last Five Years?
Dec 29
How Should Investors Feel About Sinopharm Tech Holdings' (HKG:8156) CEO Remuneration?
Nov 24Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 8156 has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Uzun Vadeli Yükümlülükler: 8156 has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 8156 has negative shareholder equity, which is a more serious situation than a high debt level.
Borcun Azaltılması: 8156's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: Insufficient data to determine if 8156 has enough cash runway based on its current free cash flow.
Tahmini Nakit Akışı: Insufficient data to determine if 8156 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.